Results
106
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
106 companies
Biotage
Market Cap: SEK 7.2b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 90.55
7D
3.7%
1Y
-44.6%
BioGaia
Market Cap: SEK 10.2b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 100.70
7D
2.2%
1Y
-15.0%
Camurus
Market Cap: SEK 33.2b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMX
SEK 566.00
7D
4.3%
1Y
19.5%
Bonesupport Holding
Market Cap: SEK 20.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 309.40
7D
3.6%
1Y
30.2%
Newbury Pharmaceuticals
Market Cap: SEK 82.5m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 3.40
7D
1.2%
1Y
-2.9%
Saniona
Market Cap: SEK 871.0m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.
SANION
SEK 6.40
7D
-5.3%
1Y
239.3%
Swedish Orphan Biovitrum
Market Cap: SEK 90.3b
An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 263.00
7D
4.9%
1Y
1.4%
Ascelia Pharma
Market Cap: SEK 297.0m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 3.09
7D
14.7%
1Y
-77.7%
Elicera Therapeutics
Market Cap: SEK 158.7m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 3.27
7D
10.7%
1Y
178.3%
Corline Biomedical
Market Cap: SEK 219.9m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 8.98
7D
3.7%
1Y
-17.6%
NextCell Pharma
Market Cap: SEK 70.5m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 0.96
7D
-18.3%
1Y
-63.3%
Devyser Diagnostics
Market Cap: SEK 1.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 89.90
7D
1.6%
1Y
-14.4%
Biovica International
Market Cap: SEK 78.4m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.80
7D
0.3%
1Y
-65.1%
AcouSort
Market Cap: SEK 55.0m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.68
7D
-1.1%
1Y
-63.2%
Lipigon Pharmaceuticals
Market Cap: SEK 17.8m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.12
7D
1.3%
1Y
-58.6%
Modus Therapeutics Holding
Market Cap: SEK 46.0m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.28
7D
2.8%
1Y
24.9%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.
GENO
SEK 19.92
7D
8.7%
1Y
-30.3%
Xbrane Biopharma
Market Cap: SEK 298.2m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.19
7D
6.7%
1Y
-46.5%
Vitrolife
Market Cap: SEK 20.9b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 154.60
7D
2.0%
1Y
-8.0%
Moberg Pharma
Market Cap: SEK 359.5m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 7.70
7D
6.9%
1Y
-71.6%
AlzeCure Pharma
Market Cap: SEK 218.1m
A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.47
7D
-0.8%
1Y
23.5%
Active Biotech
Market Cap: SEK 120.6m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.098
7D
40.0%
1Y
-82.2%
BioArctic
Market Cap: SEK 14.9b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 168.10
7D
3.8%
1Y
-13.3%
Oncopeptides
Market Cap: SEK 447.5m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.98
7D
-0.6%
1Y
-56.3%
Swedencare
Market Cap: SEK 5.7b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 35.60
7D
0.3%
1Y
-40.4%
Cinclus Pharma Holding
Market Cap: SEK 473.8m
A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.
CINPHA
SEK 10.18
7D
-8.9%
1Y
n/a
Magle Chemoswed Holding
Market Cap: SEK 586.8m
Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.
MAGLE
SEK 28.60
7D
7.5%
1Y
-5.3%
SenzaGen
Market Cap: SEK 145.2m
Provides non-animal tests for assessing a substance’s allergenicity.
SENZA
SEK 4.92
7D
15.8%
1Y
-24.3%
MedCap
Market Cap: SEK 5.8b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 385.50
7D
7.7%
1Y
-4.1%
Annexin Pharmaceuticals
Market Cap: SEK 143.9m
A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 0.27
7D
-6.9%
1Y
-1.1%
Xspray Pharma
Market Cap: SEK 1.3b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 35.60
7D
17.5%
1Y
-10.3%
Scandion Oncology
Market Cap: SEK 2.8m
A clinical-stage biotechnology company, develops medicines for the treatment of cancer.
SCOL
SEK 0.012
7D
-4.8%
1Y
-99.5%
Alzinova
Market Cap: SEK 172.3m
A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.93
7D
3.8%
1Y
10.4%
Biosergen
Market Cap: SEK 68.8m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.29
7D
-2.3%
1Y
-39.1%
BICO Group
Market Cap: SEK 2.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 35.86
7D
5.8%
1Y
-20.3%
AddLife
Market Cap: SEK 18.8b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 154.00
7D
7.1%
1Y
57.5%